Insulin Pumps: Diabetes Management on Earth and in Space

Insulin pumps deliver continuous subcutaneous insulin infusion (CSII), mimicking physiological basal/bolus secretion. They are transformative for type 1 diabetes — and have flown in space since 1985.

Terrestrial Use

  • Basal rates programmable by time of day.
  • Bolus calculator (carb ratio, insulin sensitivity, active insulin time).
  • CGM integration (hybrid closed loop / automated insulin delivery).
  • Improves HbA1c, reduces hypoglycemia, enhances quality of life.

Spaceflight Adaptation

  • First use: 1985 (STS-51-F, not 1975 — Charles Bassett died in 1966). Jay Apt (STS-37, 1991) and others used pumps on Shuttle.
  • Microgravity effects: Fluid shift → altered insulin absorption; pump provides stable delivery vs. injections.
  • Challenges: Thermal control (insulin denatures >30°C); radiation hardening; bubble formation in tubing; limited resupply; crew training for pump management.

Current Status

Pumps are standard for astronauts with diabetes. Artemis and future missions will require closed-loop systems with enhanced reliability and autonomy.

Space use validates pump robustness — benefits Earth patients through technology transfer.

Diabetes - Related Articles